Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology

Bladder Cancer Clinical Trial

Official title:

Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00801762
• Other study ID #: SU-10142008-1319
• Status: Completed
• Start date: September 2008
• Est. completion date: February 2015

Study information

• Verified date: April 2019
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of the study is to develop a novel approach to obtain real time optical biopsy of urinary tract pathology (e.g., bladder tumors) during urinary tract endoscopy using a novel fibered confocal microscope.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 195
• Est. completion date: February 2015
• Est. primary completion date: February 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:Research subjects with suspected urinary tract pathology (e.g., bladder tumors) who are scheduled to undergo cystoscopy with possible excisional biopsy (e.g. transurethral resection of bladder tumor) in the operating room. Exclusion Criteria:History of hypersensitivity to fluorescein; active urinary tract infection; pregnant; currently breast feeding;

Related Conditions & MeSH terms

• Bladder Cancer
• Urinary Bladder Neoplasms

Intervention

Device:
• Fibered confocal microscope

Locations

Country	Name	City	State
United States	VA Palo Alto Health Care System	Palo Alto	California

Sponsors (2)

Lead Sponsor	Collaborator
Stanford University	Mauna Kea Technologies

Country where clinical trial is conducted

United States,